Isabelle Gaudet
Overview
Explore the profile of Isabelle Gaudet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lepage C, Bayard J, Gaudet I, Paquette N, Simard M, Gallagher A
Acta Paediatr
. 2024 Sep;
114(1):164-172.
PMID: 39262313
Aim: Having a child with congenital heart disease (CHD) is stressful for parents, but research on the impact this stress can have on child development has been lacking. We investigated...
2.
Maalouf Y, Provost S, Gaudet I, Dodin P, Paquette N, Gallagher A
J Pediatr Psychol
. 2024 Aug;
49(10):731-756.
PMID: 39186682
Objective: This systematic review, performed in accordance with the PRISMA guidelines, seeks to summarize the interventions that have been developed in order to improve executive functioning and attention in children...
3.
Desrosiers J, Caron-Desrochers L, Rene A, Gaudet I, Pincivy A, Paquette N, et al.
Neurosci Biobehav Rev
. 2024 Jun;
163:105778.
PMID: 38936564
The prenatal and neonatal periods are two of the most important developmental stages of the human brain. It is therefore crucial to understand normal brain development and how early connections...
4.
Santos R, Ruzza A, Wang B, Maruff P, Schembri A, Bhatia A, et al.
Eur J Prev Cardiol
. 2023 Oct;
31(3):302-310.
PMID: 37855448
Aims: PCSK9 inhibition intensively lowers low density lipoprotein cholesterol and is well tolerated in adults and paediatric patients with familial hypercholesterolaemia (FH). HAUSER-RCT showed that 24 weeks of treatment with...
5.
Simard M, Lepage C, Gaudet I, Paquette N, Doussau A, Poirier N, et al.
BMJ Open
. 2023 Oct;
13(10):e079407.
PMID: 37848299
Introduction: Preschoolers and school-aged children with congenital heart disease (CHD) are at higher risk of attention deficit hyperactivity disorder (ADHD) compared with the general population. To this day, no randomised...
6.
Fourdain S, Provost S, Tremblay J, Vannasing P, Doussau A, Caron-Desrochers L, et al.
Child Neuropsychol
. 2023 Jan;
29(7):1088-1108.
PMID: 36718095
Patients with congenital heart disease (CHD) requiring cardiac surgery in infancy are at high risk for neurodevelopmental impairments. Neonatal imaging studies have reported disruptions of brain functional organization before surgery....
7.
The role of parenting stress in anxiety and sleep outcomes in toddlers with congenital heart disease
Lepage C, Gaudet I, Doussau A, Vinay M, Gagner C, Von Siebenthal Z, et al.
Front Pediatr
. 2023 Jan;
10:1055526.
PMID: 36683797
Objectives: This retrospective cohort study investigates how parenting stress, measured at 4 months of age by use of a classic three-dimensional parent-reported scale (Parenting Stress Index, 4th Ed. or PSI-4),...
8.
Gaudet D, Ruzza A, Bridges I, Maruff P, Schembri A, Hamer A, et al.
J Clin Lipidol
. 2022 Oct;
16(5):676-684.
PMID: 36210291
Background: Evolocumab is a fully human monoclonal antibody inhibitor of PCSK9 approved for lowering low-density lipoprotein cholesterol in adults and pediatric patients with familial hypercholesterolemia (FH). The cognitive safety of...
9.
Gaudet I, Paquette N, Doussau A, Poirier N, Simard M, Beauchamp M, et al.
Neuropsychology
. 2022 Jun;
36(6):552-564.
PMID: 35679183
Objective: Children born with congenital heart disease (CHD) are at an increased risk for various neurodevelopmental impairments. However, little is known regarding social outcomes associated with CHD, particularly during early...
10.
Gaudet I, Paquette N, Bernard C, Doussau A, Harvey J, Beaulieu-Genest L, et al.
J Pediatr
. 2021 Aug;
239:126-135.e5.
PMID: 34454950
Objective: To characterize the neuropsychological outcome of children with congenital heart disease (CHD) at age 5 years; the stability of cognitive and language abilities across childhood; and to identify early...